Soiken Holdings Inc. — Investor Relations & Filings
Soiken Holdings Inc. is a holding company focused on commercializing outcomes from medical science research. The group's core competency lies in the development and application of biomarker technology and related bioassay systems. Through its subsidiaries, the company provides a range of services, including clinical evaluation and testing for pharmaceutical and food manufacturers, and support for clinical research. In addition to its service-based operations, Soiken Holdings develops and markets its own evidence-based products. These include functional dietary supplements, high-functionality cosmetics, and functional materials for various applications. The company is also engaged in advanced research and development in areas such as gene therapy and novel pharmaceutical compounds.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 2026年6月期 第3四半期決算短信〔日本基準〕（連結） | 2026-05-13 | Japanese | |
| 確認書 | 2026-02-13 | Japanese | |
| 半期報告書－第32期(2025/07/01－2026/06/30) | 2026-02-13 | Japanese | |
| 2026年6月期 第2四半期（中間期）決算短信〔日本基準〕（連結） | 2026-02-12 | Japanese | |
| 2026年6月期期末配当予想の修正（増配）に関するお知らせ | 2025-11-13 | Japanese | |
| 2026年6月期 第1四半期決算短信〔日本基準〕（連結） | 2025-11-13 | Japanese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
4 filings
| |||||
| 48150437 | 2026年6月期 第3四半期決算短信〔日本基準〕（連結） | 2026-05-13 | Japanese | ||
| 19459483 | 確認書 | 2026-02-13 | Japanese | ||
| 19459455 | 半期報告書－第32期(2025/07/01－2026/06/30) | 2026-02-13 | Japanese | ||
| 48150438 | 2026年6月期 第2四半期（中間期）決算短信〔日本基準〕（連結） | 2026-02-12 | Japanese | ||
|
2025
11 filings
| |||||
| 48150440 | 2026年6月期期末配当予想の修正（増配）に関するお知らせ | 2025-11-13 | Japanese | ||
| 48150439 | 2026年6月期 第1四半期決算短信〔日本基準〕（連結） | 2025-11-13 | Japanese | ||
| 7919020 | 確認書 | 2025-09-24 | Japanese | ||
| 7919017 | 有価証券報告書－第31期(2024/07/01－2025/06/30) | 2025-09-24 | Japanese | ||
| 48150441 | 2026年6月期通期連結業績予想修正に関するお知らせ | 2025-08-18 | Japanese | ||
| 48150442 | 2025年6月期 決算短信〔日本基準〕（連結） | 2025-08-13 | Japanese | ||
| 48150444 | 2025年6月期通期連結業績予想（上方）修正及び配当予想の修正（復配）に関するお知らせ | 2025-05-13 | Japanese | ||
| 48150443 | 2025年6月期 第3四半期決算短信〔日本基準〕（連結） | 2025-05-13 | Japanese | ||
| 7277327 | 確認書 | 2025-02-13 | Japanese | ||
| 7277326 | 半期報告書－第31期(2024/07/01－2025/06/30) | 2025-02-13 | Japanese | ||
| 48150445 | 2025年6月期 第2四半期（中間期）決算短信〔日本基準〕（連結） | 2025-02-12 | Japanese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova Corporation
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
Soiken Holdings Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/13346/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=13346 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=13346 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=13346 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 13346}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Soiken Holdings Inc. (id: 13346)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.